Navigation Links
KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
Date:2/26/2013

ive GM-CSF may be involved in tissue damage associated with inflammatory diseases including asthma.

KB003 is a Humaneered® version of the chimeric KB002 antibody, with the same epitope target and therefore the same mechanism of action.  We plan to use KB003 for all future clinical studies in this program.

About KaloBios

KaloBios Pharmaceuticals, Inc. is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies (mAbs) designed to significantly improve the lives of seriously ill patients with difficult-to-treat diseases.

Currently, KaloBios has three drug development programs:

  • KB003, an anti-GM-CSF mAb with potential to treat inflammatory diseases, is being developed for the treatment of severe asthma and is currently enrolling patients in a 150 patient Phase 2 study in the United States, Europe and Australia.
  • KB001-A, an anti-PcrV mAb fragment, is partnered exclusively with Sanofi Pasteur and is being developed for the prevention and treatment of Pseudomonas aeruginosa (Pa) infection. KaloBios has retained rights for the cystic fibrosis (CF) indication and has initiated a 180 patient Phase 2 study in CF subjects with chronic Pa infection in the United States. Sanofi is pursuing a ventilator associated pneumonia prevention indication in the intensive care setting.
  • KB004, an anti-EphA3 mAb, has potential in treating hematologic malignancies and solid tumors. KaloBios is currently testing this drug in a Phase 1 study in subjects with hematologic malignancies.

All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding aff
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
2. KaloBios Pharmaceuticals Completes Initial Public Offering
3. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
4. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
5. Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status
6. Dr. Diana Bianchi Presents Data Demonstrating Verinata Healths Proprietary Technology Detects Genetic Abnormalities In Twin Pregnancies
7. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
8. Misonix Presents at MicroCapClub Invitational
9. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
10. Johnson & Johnson Presents Growth Strategies for Medical Devices & Diagnostics Segment
11. Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN DIEGO , July 31, 2014  Sorrento Therapeutics, ... death of Mr. Amar Singh , Chief Business Officer ... of apparent natural causes on July 30. "Sorrento ... dear friend and colleague. Our immediate thoughts go to Amar,s ... President and Chief Executive Officer. Mr. Singh ...
(Date:7/31/2014)... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... Insulin Pump, today reported its financial results for the quarter ... second quarter of 2014 to the same period of 2013: ... $5.5 million , t:slim Pump shipments grew 64 percent ... six months ended June 30, 2014 to the same period ...
(Date:7/31/2014)... 31, 2014 Nektar Therapeutics (Nasdaq: NKTR ... ended June 30, 2014. Cash and investments ... as compared to $309.1 million at March 31, 2014."The second ... as we look forward to significant milestones for a number ... and Chief Executive Officer of Nektar. "The first of these ...
Breaking Medicine Technology:Sorrento Announces the Unexpected Death of its Chief Business Officer 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14
... , THOUSAND OAKS, Calif., Dec. 3 Each year, hundreds ... Europe participate in the Amgen Scholars Program to gain hands-on ... universities. Now, the Amgen Scholars - past, present and ... Scholars Community at www.amgenscholars.com . , "The new ...
... MARQUETTE, Mich., Dec. 3 Pioneer Surgical Technology, Inc., ... awards in the Cervical Spine Care category at the ... Francisco, California in conjunction with the North American Spine ... receiving awards were the NuNec® Cervical Total Disc replacement ...
Cached Medicine Technology:New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Pioneer(R) Surgical Technology, Inc. Receives Prestigious Spine Technology Awards 2
(Date:8/1/2014)... OR (PRWEB) August 01, 2014 In ... called hydrotherapy – was fundamental to the practice of ... water researcher Sharon Kleyne, water therapy has been relegated ... time when climate change, water shortages, drought and pollution ... diseases, the Sharon Kleyne Hour Power of Water host ...
(Date:8/1/2014)... According to the Suspension Revolution 2.0 PDF review recently ... and women who want to get ripped abdominals within a ... 27 intense workouts that help blast fat and gain muscle ... Suspension Revolution 2.0 program provides users with easy tips and ... plans that help keep fit and stay healthy ...
(Date:8/1/2014)... August 01, 2014 Blindness is a ... that the scientists of today, despite well-meaning efforts, still have ... a definite treatment for reversing blindness that does not involve ... this is where alternative medicine takes the “slack” from the ... expensive treatments or harmful surgeries. , Alternative health specialist ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Online retailer ... offering a low price guarantee on their inventory of ... adult diapers, wipes, and pads along with other personal ... can be to find a line of incontinence products ... you find one that works for you, you shouldn't ...
(Date:8/1/2014)... York, US (PRWEB) August 01, 2014 ... DataSite in partnership with PitchBook presents the 3Q 2014 ... all U.S private equity investment, exits and fundraising activity ... useful insight to help plan for private equity endeavors ... the registration form to download it now. , About ...
Breaking Medicine News(10 mins):Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 3Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 2Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 3Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2Health News:Disposable Medical Express Offering Low Price Guarantee On Tranquility Products 2Health News:Register to Download Merrill DataSite's Report: PitchBook 3Q 2014 Private Equity Breakdown Report 2
... of a recent study researchers say weight gain after age ... for postmenopausal women who // are not taking hormone replacement ... ages 50 to 74, by asking them about their weight ... women have been periodically asked to provide updates on their ...
... in as little as two days of physical inactivity, the ... and other related diseases.// ,Researchers conducted a study in ... stayed inactive. When the rats stopped running for two days ... of sugar taken into the muscle in response to insulin ...
... New research suggests weight loss may be an early ... loss begins before the onset of // definite dementia ... ,Weight loss in the elderly is common and may ... been documented in people who already have dementia. For ...
... surgery may be at higher risk for bone fractures, say ... For the study, nearly 20 percent of men treated with ... diagnosis, compared to about 13 percent of men who did ... given to men with locally advanced cancers and the therapy ...
... estrogen may provide protection against colon cancer. For the ... and followed their progress for one year. The diets were ... one contained milk protein, and diet two had soy protein. ... diets contained soy protein with the addition of an estrogen ...
... genetic discovery could help give insight into a very deadly ... that codes for the progesterone receptor increase a woman’s risk ... to a higher ovarian cancer risk as well as a ... used biological samples from an ongoing study and examined the ...
Cached Medicine News:
The CGPL capsulotomy contact glass was designed by Riquin, Fankhauser et al. for the dissection of opacified posterior lens capsules and membranes in the pupillary and retropupillary space with the Y...
The CGAL gonioscopic contact glass was designed by Roussel and Fankhauser for,laser treatments of the chamber angle. It reduces the laser spot by a factor of 1.5 as compared to a Goldmann Glass....
The CGRL is a Wide Angle Contact Glass designed for laser photocoagulation and diagnosis of the retina....
The classic Goldmann Glass. Designed to work with argon/YAG Lasers....
Medicine Products: